The Minnesota Department of Health has identified a 13th Minnesota patient with an infection following treatment with contaminated steroid medications.

The patient does not have meningitis, but the case is being included in the ongoing tally of patients in a nationwide outbreak because she has a fungal infection after being treated with implicated medications from New England Compounding Center, according to a news release dated Thursday, Nov. 15, from the Health Department.

The latest patient is a woman in her 20s with osteomyelitis -- an infection that occurs inside the bone. She is not hospitalized.

One patient in a previously reported Minnesota case also had an infection of the bone.

"Infected fluid collections, or abscesses, occurring at the site where patients received the contaminated injection have also been identified in a number of cases in other states," the Health Department said.

The national outbreak includes 461 cases spread across 19 states. A total of 32 outbreak patients have died, according to the U.S. Centers for Disease Control and Prevention.

The Health Department advised that doctors seeing patients who received contaminated products from the New England compounding pharmacy should "have a low threshold for further evaluation of patients." The evaluation could include imaging tests to look for infections in the bone or abscesses, according to the department.